<?xml version="1.0" encoding="UTF-8"?>
<ref id="B30">
 <label>30</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Yu</surname>
    <given-names>G</given-names>
   </name>
   <name>
    <surname>Shen</surname>
    <given-names>Y</given-names>
   </name>
   <name>
    <surname>Xu</surname>
    <given-names>X</given-names>
   </name>
   <name>
    <surname>Zhong</surname>
    <given-names>F</given-names>
   </name>
  </person-group>. 
  <article-title>Anlotinib for refractory advanced non-small-cell lung cancer: A systematic review and meta-analysis</article-title>. 
  <source>PloS One</source> (
  <year>2020</year>) 
  <volume>15</volume>:
  <elocation-id>e0242982</elocation-id>. Â 
  <pub-id pub-id-type="doi">10.1371/journal.pone.0242982</pub-id>
  <pub-id pub-id-type="pmid">33253313</pub-id>
 </mixed-citation>
</ref>
